相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Use of checkpoint inhibitors in liver transplant recipients
Stefan Munker et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction
Xiao-Lei Shi et al.
JOURNAL OF HEPATOLOGY (2016)
分享论文
